health
Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
HIGH confianza
Cobertura (321 artículos)
Aún no se ha reunido cobertura para este tema.